| Patents for A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445) |
|---|
| 10/13/2005 | WO2005094884A2 Boron containing nanoparticles targeted to t-cells |
| 10/13/2005 | DE10031851B4 Photodynamische Behandlung und UV-B-Bestrahlung einer Thrombozyten-Suspension Photodynamic treatment and UV-B irradiation of a platelet suspension |
| 10/12/2005 | EP1584622A2 Compounds for the photodecontamination of pathogens in blood |
| 10/12/2005 | EP1584317A1 Apparatus for hydrotherapy or relaxation therapy |
| 10/12/2005 | EP1583775A2 Peptide compound containing boron |
| 10/12/2005 | EP1583569A2 Ultrasonic catheter with axial energy field |
| 10/12/2005 | EP1583525A1 Use of porphyrin synthesis substances for carrying out phototherapy and for curing skin and articulation diseases |
| 10/12/2005 | EP1294918B1 Replication deficient adenoviral tnf vector |
| 10/12/2005 | CN1222526C Chlorophyll and bacteriochlorophyll esters, and their preparation |
| 10/12/2005 | CN1222309C Transfer of molecules into cytosol of cells |
| 10/11/2005 | US6953570 For therapy of tumors |
| 10/06/2005 | WO2005092286A2 Metallic nano-particles and discrete polymer-coated nano-particles |
| 10/06/2005 | WO2005091704A2 Magnetic nanoparticles of noble metals |
| 10/06/2005 | US20050222116 Porphyrin oxygen infusion preparation for increasing oxygen concentration in tumor tissue |
| 10/06/2005 | US20050222013 Methods for the use of inhibitors of histone deacetylase as synergistic agents in cancer therapy |
| 10/06/2005 | US20050220780 Pharmaceutical composition having thrombolytic anti-inflammatory and cytoprotective properties |
| 10/05/2005 | CN1678353A New anti-cancer compounds |
| 10/05/2005 | CN1678342A Treatment for eye disorder |
| 10/05/2005 | CN1221286C Irradiation of ispaghula and product thereof |
| 10/05/2005 | CN1221214C Apparatus and method for making gas-filled utricle of optimal size |
| 10/04/2005 | US6951640 Imaging tumors using organometallic porphyrin |
| 09/29/2005 | WO2005089813A2 Receptor-avid exogenous optical contrast and therapeutic agents |
| 09/29/2005 | WO2005089398A2 Method for the delivery of sustained release agents |
| 09/29/2005 | US20050214380 Nanobioprocessor for protein and cell therapy |
| 09/29/2005 | DE10083574B4 Verfahren zum Aufbringen einer medizinischen oder biologisch entlastenden Wirkung auf ein Quellensystem und Weiterleitung an ein aus wenigstens einer strombetriebenen Einrichtung bestehendes Zielsystem A method of applying a medical or biological relieving effect on a source system and forwarded to an existing from at least one electrically powered device target system |
| 09/29/2005 | CA2560261A1 Method for the delivery of sustained release agents |
| 09/28/2005 | EP1578958A2 Method for suppressing immune system response to transplanted tissue or cells |
| 09/28/2005 | EP1578454A1 Ultrasound contrast using halogenated xanthenes |
| 09/28/2005 | CN1674922A Methods of treating angiogenesis, tumor growth, and metastasis |
| 09/28/2005 | CN1674908A Therapeutic combinations of erb B kinase inhibitors and antineoplastic therapies |
| 09/28/2005 | CN1674891A Porphyrin oxygen infusion preparation for increasing oxygen concentration in tumor tissue |
| 09/27/2005 | US6949753 Device and method for photoactivation |
| 09/27/2005 | US6949620 Polymeric micellar structure |
| 09/27/2005 | US6949341 Diagnosing genetic disorders |
| 09/22/2005 | WO2005087271A1 Compositions comprising cells and magnetic materials for targeted delivery |
| 09/22/2005 | US20050209298 treating rheumatoid arthritis by photodynamic therapy (PDT), by administering an iminochlorin aspartic acid porphyrin derivative called ATX-S10 sodium salt; determining the location of a sentinel lymph node and the presence of cancer metastasis; compounds from US patent 6063777 |
| 09/22/2005 | US20050208070 From Ganoderma lucidum, Salvia miltiorrhiza, and Scutellaria barbata |
| 09/22/2005 | US20050207976 High energy phototherapeutic agents |
| 09/21/2005 | EP1575414A2 Methods and devices for detection and therapy of atheromatous plaque |
| 09/21/2005 | EP1028756B1 Water soluble paclitaxel conjugates combined with irradiation for the treatment of cancer |
| 09/21/2005 | CN1219551C Conjugates made of metal complexes and oligonucleotides |
| 09/15/2005 | WO2005084754A2 Cancer treatment with topoisomerase-ii inhibitor, a bis-dioxypiperazine and radiation |
| 09/15/2005 | WO2004101516A3 Amphiphilic trisulfonated porphyrazines for photodynamic applications in medicine |
| 09/15/2005 | US20050201939 Dye-peptide complex; supplying to tumor cells; for diagnostic imaging and therapy; biocompatibility |
| 09/15/2005 | CA2557857A1 Cancer treatment with topoisomerase-ii inhibitor, a bis-dioxypiperazine and radiation |
| 09/14/2005 | EP1572239A1 Method of using a cox-2 inhibitor and a topoisomerase ii inhibitor as a combination therapy in the treatment of neoplasia |
| 09/14/2005 | CN1668327A Transdermal botulinum toxin compositions |
| 09/13/2005 | US6944493 Indocyanine green (ICG) compositions and related methods of use |
| 09/13/2005 | US6942656 Method for accurate optical treatment of an eye's fundus |
| 09/08/2005 | US20050196401 Energy-activated targeted cancer therapy |
| 09/08/2005 | US20050196340 Synergistic mixtures; antitumor agents; anticancer agents |
| 09/07/2005 | EP1570859A2 Improved treatment of neovascularization |
| 09/07/2005 | EP1569630A1 Methods for preventing phototoxic damage during photodynamic therapy |
| 09/07/2005 | CN1665535A Perylenequinones for use with immunotherapy agents |
| 09/07/2005 | CN1665532A Calicheamicin derivative-carrier conjugates |
| 09/06/2005 | US6939963 Use as catalyst , in photovoltaic cells, drugs for diagnosis and photodynamic treatment of tumors or as chemical intermediates; metal complexes of 2,17-Bis(chlorosulfonyl)-5,10,15-tris(pentafluorophenyl)corrole |
| 09/06/2005 | US6939532 Versatile hydrophilic dyes |
| 09/01/2005 | WO2005079843A1 Novel liposome |
| 09/01/2005 | WO2005079820A1 Immunopotentiator |
| 09/01/2005 | WO2005079155A2 Photoreactive compound specifically binding to calcium binding proteins |
| 09/01/2005 | CA2556054A1 Photoreactive compound specifically binding to calcium binding proteins |
| 08/31/2005 | EP1567163A2 Method of treating nausea, vomiting, retching or any combination thereof |
| 08/31/2005 | EP1567049A1 Microparticles having a matrix interior useful for ultrasound triggered delivery of drugs into the bloodstream |
| 08/31/2005 | EP1259264A4 Method for treating inflammatory bowel disease and other forms of gastrointestinal inflammation |
| 08/31/2005 | CN1660427A Extracorporeal photopheresis in combination with anti-tnf treatment |
| 08/30/2005 | US6936469 Methods for delivering nucleic acid molecules into cells and assessment thereof |
| 08/30/2005 | US6936044 Method and apparatus for the stimulation of hair growth |
| 08/25/2005 | WO2005077457A1 Photodynamic therapy for the treatment of prostatic conditions |
| 08/25/2005 | WO2005077330A1 Electromagnetic radiation addressable materials |
| 08/25/2005 | WO2005053682A3 Use of beta-lapachone for protecting against radiation injury |
| 08/25/2005 | WO2005044182A3 Compositions of botanical extracts for cancer therapy |
| 08/25/2005 | US20050187261 For hepatitis C; histone deacetylase inhibitors, anticarcinogenic agents; N-hydroxy-4-{[(benzofuran-, benzothiophen-, or indol-)-2-ylcarbonylamino]alkoxy}benzamides; amidation of a benzoic acid, benzoate, benzoyl halide with hydroxyamine |
| 08/25/2005 | US20050187207 Immuno-adjuvant PDT treatment of metastatic tumors |
| 08/25/2005 | CA2554816A1 Photodynamic therapy for the treatment of prostatic conditions |
| 08/24/2005 | EP1565181A2 Deguelin as a chemopreventive agent for lung cancer |
| 08/24/2005 | EP1276749B1 Photo-labile coumarinylmethyl esters of cyclic nucleotides, method for the production and use thereof |
| 08/24/2005 | EP1204426B1 Medical preparation for treating arthrosis, arthritis and other rheumatic joint diseases |
| 08/24/2005 | EP1001770B1 Tazarotene and uvb phototherapy treatment for psoriasis |
| 08/24/2005 | CN1659288A Method to inhibit cell growth using oligonucleotides |
| 08/24/2005 | CN1658924A Method of treating biological materials with translating electrical fields and electrode polarity reversal |
| 08/24/2005 | CN1658902A Thermosensitive polymer carriers having a modifiable physical structure for biochemical analysis, diagnosis and therapy |
| 08/24/2005 | CN1658804A Low intensity light therapy for the manipulation of fibroblast-derived mammalian cells and collagen |
| 08/23/2005 | US6933287 Dramatic simplification of a method to treat neoplastic disease by radiation |
| 08/23/2005 | US6933285 Flavin N-oxides: new anti-cancer agents and pathogen eradication agents |
| 08/18/2005 | WO2005074987A1 Photodynamic therapy for the treatment of acne |
| 08/18/2005 | US20050182461 Shape-adaptable and spectral-selective distributed light sources using passive host medium |
| 08/18/2005 | US20050180917 Delivery of neutron capture elements for neutron capture therapy |
| 08/18/2005 | CA2554591A1 Photodynamic therapy for the treatment of acne |
| 08/17/2005 | EP1563788A2 Microporation of human skin for drug delivery and monitoring applications |
| 08/17/2005 | EP1562642A1 Device and process for treating a liquid medium using ultrasound in preventing the growth of hyperproliferative or infected cells |
| 08/17/2005 | EP1562597A2 Methods of using and compositions comprising immunomodulatory compounds for treatment and management of macular degeneration |
| 08/17/2005 | EP1429617A4 Methods for sterilizing preparations of digestive enzymes |
| 08/17/2005 | CN1655828A Method of inactivating microorganisms in a fluid using ultraviolet radiation |
| 08/17/2005 | CN1655815A Process for the preparation and activation of substances and a means of producing same |
| 08/17/2005 | CN1655814A Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 08/16/2005 | US6930220 Adhering therapeutic tool |
| 08/11/2005 | WO2004089300A3 Sapphyrins and uses thereof |
| 08/11/2005 | US20050177207 Synergism of photodynamic and electropermeation effect on cell vitality as a novel cytotoxic agent |
| 08/11/2005 | US20050175702 Contains magnetic and/or metallic colloids; produced by suspension polymerization |
| 08/11/2005 | US20050175636 Containing stabilized neurotoxin as analgesic and skin penetration enhancing agent; inflammation and/or pain reduction |